Cargando…
Quantifying Clinical HPV4 Dose Inefficiencies in a Safety Net Population
PURPOSE: HPV4 is the most expensive vaccine requiring three appropriately timed doses to provide maximal efficacy against two oncogenic HPV types. The primary purpose of this study is to quantify the use of HPV4 vaccine in a safety net health care system in terms of its inefficiencies. METHODS: A re...
Autores principales: | Harper, Diane M., Verdenius, Inge, Ratnaraj, Felicia, Arey, Anne M., Rosemergey, Beth, Malnar, Gerard J., Wall, Jeffrey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3819328/ https://www.ncbi.nlm.nih.gov/pubmed/24223131 http://dx.doi.org/10.1371/journal.pone.0077961 |
Ejemplares similares
-
In a Safety Net Population HPV4 Vaccine Adherence Worsens as BMI Increases
por: Harper, Diane M., et al.
Publicado: (2014) -
Predictors of Three Dose On-Time Compliance with HPV4 Vaccination in a Disadvantaged, Underserved, Safety Net Population in the US Midwest
por: Verdenius, Inge, et al.
Publicado: (2013) -
Urban and Rural Safety Net Health Care System Clinics: No Disparity in HPV4 Vaccine Completion Rates
por: Sandri, Kelly Jo, et al.
Publicado: (2014) -
Quantifying the benefits of inefficient walking: Monty Python inspired laboratory based experimental study
por: Gaesser, Glenn A, et al.
Publicado: (2022) -
HPV vaccination bridges to HPV screening
por: Harper, Diane M, et al.
Publicado: (2020)